The European interventional cardiology market is expected to remain flat through 2017, with a projected value of about 740 million euros ($1 billion U.S.), according to the Toronto-based market research firm Millennium Research Group (MRG).
The company predicts procedure growth will average about 1% per year, with revenue growth remaining flat. The growth that takes place will be in the intravascular imaging market, particularly for optical coherence tomography and intravascular ultrasound (IVUS).
MRG's new report, "European Markets for Interventional Cardiolology Devices 2013" includes unit, procedures, average selling price, and revenue information. It also discusses market drivers and limitations as well as a competitive analysis of coronary stents, percutaneous transluminal coronary angioplasty balloon catheters, pressure guidewires, and intravascular imaging catheters.
